It is a pharma private limited company based in New Delhi, Delhi, India, established in 2020.
2020 | New Delhi, Delhi, India | ActiveInthera Pharmamed Biotech Private Limited, a active private limited company, was established on 14 June 2020 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74110DL2020PTC364814. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Ashish Kumar (Director), Mridul Modgil (Director). Past directors included Dharmender Gupta, Ashish Kumar, Rockey Sharma. Its latest AGM occurred on 30 August 2025, with the balance sheet filed on 31 March 2025. It is based at Unit No 108,Metroplex East Mall, Plot No 21,District Centre, Laxmi Nagar, New Delhi, Delhi, 110092.
U74110DL2020PTC364814
364814
14 June 2020
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Inthera Pharmamed Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashish Kumar | Director | 04 Aug 2023 | Current |
| Mridul Modgil | Director | 12 Apr 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 07 Dec 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 07 Dec 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 01 Jun 2022 | Past |
| Pramod Abcsdd | Director | 01 Jun 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Inthera Pharmamed Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.52% decrease. The company also saw a substantial improvement in profitability, with a 23.75% increase in profit. The company's net worth observed a substantial decline by a decrease of 30.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Inthera Pharmamed Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Inthera Pharmamed Biotech has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Inthera Pharmamed Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inthera Pharmamed Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Inthera Pharmamed Biotech Private Limited last Annual general meeting of members was held on 30 Aug 2025 as per latest MCA records. was completed.
Inthera Pharmamed Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Progress on Ashish Kumar was appointed as a Director was appointed as a Director on 04 Aug 2023 & has been associated with this company since 2 years 3 months . was documented.
The activity Mridul Modgil was appointed as a Director was appointed as a Director on 12 Apr 2023 & has been associated with this company since 2 years 7 months . was completed.
The activity Inthera Pharmamed Biotech Private Limited was registered on 14 Jun 2020 with Roc Delhi & aged 5 years 5 months as per MCA records. was completed.
The CIN of Inthera Pharmamed Biotech Private Limited is U74110DL2020PTC364814.
Inthera Pharmamed Biotech Private Limited is headquartered at Unit No 108,Metroplex East Mall, Plot No 21,District Centre, Laxmi Nagar, New Delhi, Delhi, 110092.
Inthera Pharmamed Biotech Private Limited was incorporated on 14 June 2020.
The current directors of Inthera Pharmamed Biotech Private Limited are
The primary industry of Inthera Pharmamed Biotech Private Limited is Trade.
Inthera Pharmamed Biotech Private Limited is unlisted.
The authorized capital of Inthera Pharmamed Biotech Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Inthera Pharmamed Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX